18 results on '"Ardiles L"'
Search Results
2. POS-308 Characterization of pre-clinical chronic kidney disase (sCKD) in the population of Chile
- Author
-
Castillo-Montes, A.A., primary, Castillo, M., additional, and Ardiles, L., additional
- Published
- 2021
- Full Text
- View/download PDF
Catalog
3. POS-757 COVID-19 INFECTION IN CHILEAN RENAL TRANSPLANTED PATIENTS: INCIDENCE AND CLINICAL OUTCOMES. COLABORATIVE MULTICENTRIC STUDY
- Author
-
Pefaur Penna, J., primary, Toro, L., additional, Rosati, P., additional, Badilla, X., additional, Ardiles, L., additional, Rocca, X., additional, Valenzuela, M., additional, Mur, P., additional, Boltansky, A., additional, Diaz, C., additional, Tapia, B., additional, Fernandez, A., additional, Ortiz, M., additional, Elgueta, L., additional, and Sanchez, J.E., additional more...
- Published
- 2021
- Full Text
- View/download PDF
4. Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria
- Author
-
Ardiles, L G, Loyola, F, Ehrenfeld, P, Burgos, M E, Flores, C A, Valderrama, G, Caorsi, I, Egido, J, Mezzano, S A, and Figueroa, C D
- Published
- 2006
5. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis
- Author
-
Mezzano, S., primary, Droguett, A., additional, Eugenia Burgos, M., additional, Aros, C., additional, Ardiles, L., additional, Flores, C., additional, Carpio, D., additional, Carvajal, G., additional, Ruiz-Ortega, M., additional, and Egido, J., additional more...
- Published
- 2007
- Full Text
- View/download PDF
6. NF- B activation and overexpression of regulated genes in human diabetic nephropathy
- Author
-
Mezzano, S., primary, Aros, C., additional, Droguett, A., additional, Burgos, M. E., additional, Ardiles, L., additional, Flores, C., additional, Schneider, H., additional, Ruiz-Ortega, M., additional, and Egido, J., additional more...
- Published
- 2004
- Full Text
- View/download PDF
7. Case report: Thrombotic thrombocytopenic purpura in a pregnant woman with lupus membranous nephropathy: a diagnostic challenge.
- Author
-
Leiva M, Navarro G, Carpio JD, and Ardiles L
- Abstract
A 27-year-old female at 20th week of pregnancy was admitted with edema, foamy urine, but normal blood pressure. Her blood count was normal, she had proteinuria of 3 g/day, creatinine 0.4 mg/dl, albumin 2.4 g/dl, and cholesterol 355 mg/dl. Antinuclear antibodies 1/160, but Anti-DNA, anticardiolipin antibodies and lupus anticoagulant were negative, with normal serum C3 and C4. A renal biopsy showed secondary membranous glomerulopathy, most likely lupus class V pure. Steroids, azathioprine, and aspirin were initiated, up to 28 weeks of pregnancy, when she developed severe hypertension, photopsia, headache, anasarca, extensive bruising of the extremities, severe anemia, thrombocytopenia, and creatinine rose to 2.09 mg/dl with preserved diuresis. A female infant, 1045 grams, was delivered by emergency caesarean section. Following the surgery, she experienced diplopia, dysarthria, bradypsychia, and sensory alterations in the lower extremities, necessitating emergency hemodialysis due to pulmonary congestion. Blood smear revealed schistocytes, LDH elevated at 1148 IU/L, while transaminases and liver function remained normal, suggesting thrombotic thrombocytopenic purpura. ADAMTS13 revealed 6% activity with the presence of inhibitor. Mycophenolate and daily plasmapheresis with fresh frozen plasma replacement yielded unsatisfactory response, unaffected by the addition of methylprednisolone pulses and rituximab. Eventually, intravenous cyclophosphamide was introduced, resulting in complete hematological remission and normalization of ADAMTS13, however dialysis-dependence persisted and four years later, right renal cancer prompted bilateral nephrectomy. After a total follow-up of six years, she remained free of neoplastic recurrence and lupus activity, receiving prednisone and hydroxychloroquine. The differential diagnosis of microangiopathic syndrome in a pregnant lupus patient is discussed., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Leiva, Navarro, Carpio and Ardiles.) more...
- Published
- 2024
- Full Text
- View/download PDF
8. Hyperphosphatemia With Normal Kidney Function Associated With Genetic Variants of GALNT3 .
- Author
-
Schulz I, Kutscher A, Krall P, Carpio D, and Ardiles L
- Published
- 2023
- Full Text
- View/download PDF
9. Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile.
- Author
-
Díaz-Dinamarca DA, Díaz P, Barra G, Puentes R, Arata L, Grossolli J, Riveros-Rodriguez B, Ardiles L, Santelises J, Vasquez-Saez V, Escobar DF, Soto D, Canales C, Díaz J, Lamperti L, Castillo D, Urra M, Zuñiga F, Ormazabal V, Nova-Lamperti E, Benítez R, Rivera A, Cortes CP, Valenzuela MT, García-Escorza HE, and Vasquez AE more...
- Subjects
- Humans, Immunity, Humoral, SARS-CoV-2, BNT162 Vaccine, Chile, Vaccination, Antibodies, Neutralizing, COVID-19 prevention & control, Vaccines
- Abstract
Introduction: Severe acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million people receiving a complete vaccination scheme. The final target is 18 million individuals. The most common vaccines used in Chile are CoronaVac (Sinovac) and BNT162b2 (Pfizer-Biotech). Given the global need for vaccine boosters to combat the impact of emerging virus variants, studying the immune response to SARS-CoV-2 is crucial. In this study, we characterize the humoral immune response in inoculated volunteers from Chile who received vaccination schemes consisting of two doses of CoronaVac [CoronaVac (2x)], two doses of CoronaVac plus one dose of BNT162b2 [CoronaVac (2x) + BNT162b2 (1x)], and three doses of BNT162b2 [BNT162b2 (3x)]., Methods: We recruited 469 participants from Clínica Dávila in Santiago and the Health Center Víctor Manuel Fernández in the city of Concepción, Chile. Additionally, we included participants who had recovered from COVID-19 but were not vaccinated (RCN). We analyzed antibodies, including anti-N, anti-S1-RBD, and neutralizing antibodies against SARS-CoV-2., Results: We found that antibodies against the SARS-CoV-2 nucleoprotein were significantly higher in the CoronaVac (2x) and RCN groups compared to the CoronaVac (2x) + BNT162b2 (1x) or BNT162b2 (3x) groups. However, the CoronaVac (2x) + BNT162b2 (1x) and BNT162b2 (3x) groups exhibited a higher concentration of S1-RBD antibodies than the CoronaVac (2x) group and RCN group. There were no significant differences in S1-RBD antibody titers between the CoronaVac (2x) + BNT162b2 (1x) and BNT162b2 (3x) groups. Finally, the group immunized with BNT162b2 (3x) had higher levels of neutralizing antibodies compared to the RCN group, as well as the CoronaVac (2x) and CoronaVac (2x) + BNT162b2 (1x) groups., Discussion: These findings suggest that vaccination induces the secretion of antibodies against SARS-CoV-2, and a booster dose of BNT162b2 is necessary to generate a protective immune response. In the current state of the pandemic, these data support the Ministry of Health of the Government of Chile's decision to promote heterologous vaccination as they indicate that a significant portion of the Chilean population has neutralizing antibodies against SARS-CoV-2., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Díaz-Dinamarca, Díaz, Barra, Puentes, Arata, Grossolli, Riveros-Rodriguez, Ardiles, Santelises, Vasquez-Saez, Escobar, Soto, Canales, Díaz, Lamperti, Castillo, Urra, Zuñiga, Ormazabal, Nova-Lamperti, Benítez, Rivera, Cortes, Valenzuela, García-Escorza and Vasquez.) more...
- Published
- 2023
- Full Text
- View/download PDF
10. Refractory Massive Ascites: An Unusual Presentation of Nephrogenic Diabetes Insipidus.
- Author
-
Pezantes MI, Krall P, Manríquez F, Arce I, and Ardiles L
- Published
- 2021
- Full Text
- View/download PDF
11. Effect of CYP3A4 , CYP3A5 , MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients.
- Author
-
Contreras-Castillo S, Plaza A, Stojanova J, Navarro G, Carmona R, Corvalán F, Cerpa L, Sandoval C, Muñoz D, Leiva M, Castañeda LE, Farias N, Alvarez C, Llull G, Mezzano S, Ardiles L, Varela N, Rodríguez MS, Flores C, Cayún JP, Krall P, and Quiñones LA more...
- Abstract
Cyclosporine (CsA) and tacrolimus (TAC) are immunosuppressant drugs characterized by a narrow therapeutic range and high pharmacokinetic variability. The effect of polymorphisms in genes related to the metabolism and transport of these drugs, namely CYP3A4 , CYP3A5 , MDR1 and POR genes, has been evaluated in diverse populations. However, the impact of these polymorphisms on drug disposition is not well established in Latin American populations. Using TaqMan ® probes, we determined the allelic frequency of seven variants in CYP3A4 , CYP3A5 , MDR1 and POR in 139 Chilean renal transplant recipients, of which 89 were treated with CsA and 50 with TAC. We tested associations between variants and trough and/or 2-hour concentrations, normalized by dose (C
0 /D and C2 /D) at specific time points post-transplant. We found that CYP3A5*3/*3 carriers required lower doses of TAC. In TAC treated patients, most CYP3A5*3/*3 carriers presented higher C0 /D and a high proportion of patients with C0 levels outside the therapeutic range relative to other genotypes. These results reinforce the value of considering CYP3A5 genotypes alongside therapeutic drug monitoring for TAC treated Chilean kidney recipients., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Contreras-Castillo, Plaza, Stojanova, Navarro, Carmona, Corvalán, Cerpa, Sandoval, Muñoz, Leiva, Castañeda, Farias, Alvarez, Llull, Mezzano, Ardiles, Varela, Rodríguez, Flores, Cayún, Krall and Quiñones.) more...- Published
- 2021
- Full Text
- View/download PDF
12. Kidney injury in systemic lupus erythematosus: lack of correlation between clinical and histological data.
- Author
-
Fulgeri C, Carpio JD, and Ardiles L
- Subjects
- Adolescent, Adult, Correlation of Data, Female, Humans, Kidney Diseases pathology, Male, Middle Aged, Young Adult, Kidney Diseases diagnosis, Kidney Diseases etiology, Lupus Erythematosus, Systemic complications
- Abstract
Background: The existence and type of renal involvement influences the prognosis of systemic lupus erythematosus and this information may be critical when it comes to taking appropriate therapeutic decisions., Objective: To evaluate statistical correlations between clinical and histological data in patients with biopsied lupus nephropathy., Methods: Review of clinical information in adult kidney biopsy requests reported between 2002 and 2014 with a definitive clinical and histopathological diagnosis of renal involvement in systemic lupus erythematosus., Results: 134 cases (86% women), aged 15-59 years. Indication for renal biopsy: asymptomatic urinary abnormalities (30%), nephrotic proteinuria without hypoalbuminaemia (9%), nephrotic syndrome (19%), renal failure (40%) and two cases without clinical renal manifestations. The most common lesions were purely proliferative (68%). In patients with asymptomatic urinary abnormalities, 35% were class IV, 30% class III, 23% mixed, 10% class V and 2% class II. In subjects with nephrotic proteinuria, 75% were class IV, 17% mixed and 8% class III. In nephrotic syndrome patients, 46% were class IV, 27% class V, 19% mixed and 8% class III. In renal failure subjects, 67% were class IV, 22% mixed, 7% class III and 4% class V. These proportions were not statistically different. Although class IV showed the worst renal function, almost half (44%) of those without renal failure belonged to this class., Conclusion: We could not demonstrate a consistent clinical-pathological relationship that predicts patterns or severity of histological findings based on the clinical profile in patients with systemic lupus erythematosus and renal manifestations. These results highlight the importance of biopsy as a key diagnostic tool in this disease., (Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.) more...
- Published
- 2018
- Full Text
- View/download PDF
13. Tubular overexpression of gremlin induces renal damage susceptibility in mice.
- Author
-
Droguett A, Krall P, Burgos ME, Valderrama G, Carpio D, Ardiles L, Rodriguez-Diez R, Kerr B, Walz K, Ruiz-Ortega M, Egido J, and Mezzano S
- Subjects
- Animals, Cell Line, Disease Susceptibility, Folic Acid adverse effects, Gene Expression, Humans, Kidney Tubules drug effects, Mice, Mice, Transgenic, Phenotype, Intercellular Signaling Peptides and Proteins genetics, Kidney Tubules injuries, Kidney Tubules metabolism
- Abstract
A growing number of patients are recognized worldwide to have chronic kidney disease. Glomerular and interstitial fibrosis are hallmarks of renal progression. However, fibrosis of the kidney remains an unresolved challenge, and its molecular mechanisms are still not fully understood. Gremlin is an embryogenic gene that has been shown to play a key role in nephrogenesis, and its expression is generally low in the normal adult kidney. However, gremlin expression is elevated in many human renal diseases, including diabetic nephropathy, pauci-immune glomerulonephritis and chronic allograft nephropathy. Several studies have proposed that gremlin may be involved in renal damage by acting as a downstream mediator of TGF-β. To examine the in vivo role of gremlin in kidney pathophysiology, we generated seven viable transgenic mouse lines expressing human gremlin (GREM1) specifically in renal proximal tubular epithelial cells under the control of an androgen-regulated promoter. These lines demonstrated 1.2- to 200-fold increased GREM1 expression. GREM1 transgenic mice presented a normal phenotype and were without proteinuria and renal function involvement. In response to the acute renal damage cause by folic acid nephrotoxicity, tubule-specific GREM1 transgenic mice developed increased proteinuria after 7 and 14 days compared with wild-type treated mice. At 14 days tubular lesions, such as dilatation, epithelium flattening and hyaline casts, with interstitial cell infiltration and mild fibrosis were significantly more prominent in transgenic mice than wild-type mice. Tubular GREM1 overexpression was correlated with the renal upregulation of profibrotic factors, such as TGF-β and αSMA, and with increased numbers of monocytes/macrophages and lymphocytes compared to wild-type mice. Taken together, our results suggest that GREM1-overexpressing mice have an increased susceptibility to renal damage, supporting the involvement of gremlin in renal damage progression. This transgenic mouse model could be used as a new tool for enhancing the knowledge of renal disease progression. more...
- Published
- 2014
- Full Text
- View/download PDF
14. Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.
- Author
-
Ardiles L, Cardenas A, Burgos ME, Droguett A, Ehrenfeld P, Carpio D, Mezzano S, and Figueroa CD
- Subjects
- Animals, Bradykinin pharmacology, Bradykinin B2 Receptor Antagonists, Cell Line, Female, Humans, Hypertension physiopathology, Kidney Diseases pathology, Kidney Tubules pathology, Metabolic Networks and Pathways drug effects, Metabolic Networks and Pathways physiology, Proteinuria chemically induced, Rats, Rats, Sprague-Dawley, Serum Albumin, Bovine, Sodium Chloride, Dietary adverse effects, Tissue Kallikreins urine, Transforming Growth Factor beta biosynthesis, Bradykinin analogs & derivatives, Fibrosis prevention & control, Hypertension drug therapy, Kidney Diseases prevention & control, Kinins physiology, Potassium, Dietary pharmacology, Proteinuria physiopathology, Transforming Growth Factor beta physiology
- Abstract
The albumin overload model induces proteinuria and tubulointersitial damage, followed by hypertension when rats are exposed to a hypersodic diet. To understand the effect of kinin system stimulation on salt-sensitive hypertension and to explore its potential renoprotective effects, the model was induced in Sprague-Dawley rats that had previously received a high-potassium diet to enhance activity of the kinin pathway, followed with/without administration of icatibant to block the kinin B₂ receptor (B₂R). A disease control group received albumin but not potassium or icatibant, and all groups were exposed to a hypersodic diet to induce salt-sensitive hypertension. Potassium treatment increased the synthesis and excretion of tissue kallikrein (Klk1/rKLK1) accompanied by a significant reduction in blood pressure and renal fibrosis and with downregulation of renal transforming growth factor-β (TGF-β) mRNA and protein compared with rats that did not receive potassium. Participation of the B₂R was evidenced by the fact that all beneficial effects were lost in the presence of the B₂R antagonist. In vitro experiments using the HK-2 proximal tubule cell line showed that treatment of tubular cells with 10 nM bradykinin reduced the epithelial-mesenchymal transdifferentiation and albumin-induced production of TGF-β, and the effects produced by bradykinin were prevented by pretreatment with the B₂R antagonist. These experiments support not only the pathogenic role of the kinin pathway in salt sensitivity but also sustain its role as a renoprotective, antifibrotic paracrine system that modulates renal levels of TGF-β. more...
- Published
- 2013
- Full Text
- View/download PDF
15. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
- Author
-
Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, and Egido J
- Subjects
- Adult, Biomarkers metabolism, Chemokine CCL2 genetics, Chemokine CCL5 genetics, Diabetes Mellitus, Type 2 complications, Diabetic Nephropathies etiology, Diabetic Nephropathies genetics, Diabetic Nephropathies pathology, Disease Progression, Female, Gene Expression, Gene Expression Regulation, Humans, Immunohistochemistry, In Situ Hybridization, Inflammation pathology, Kidney metabolism, Kidney pathology, Male, Middle Aged, NF-kappa B p50 Subunit, RNA, Messenger metabolism, Transcription Factor RelA, Up-Regulation, Chemokine CCL2 metabolism, Chemokine CCL5 metabolism, Diabetic Nephropathies metabolism, NF-kappa B metabolism
- Abstract
Background: Nuclear factor-kappaB (NF-kappaB) regulates genes involved in renal disease progression, such as the chemokines monocyte chemoattractant protein-1 (MCP-1) and RANTES. NF-kappaB is activated in experimental models of renal injury, and in vitro studies also suggest that proteinuria and angiotensin II could be important NF-kappaB activators. It has been proposed that locally produced MCP-1 may be involved in the development of diabetic nephropathy (DN). We examined the hypothesis that NF-kappaB could be an indicator of renal damage progression in DN., Methods: Biopsy specimens from 11 patients with type 2 diabeties and overt nephropathy were studied by southwestern histochemistry for the in situ detection of activated NF-kappaB. In addition, by immunohistochemistry and/or in situ hybridization, we studied the expression of MCP-1 and RANTES, whose genes are regulated by NF-kappaB., Results: NF-kappaB was detected mainly in cortical tubular epithelial cells and, to a lesser extent, in some glomerular and interstitial cells. A strong upregulation of MCP-1 and RANTES was observed in all the cases, mainly in tubular cells, and there was a strong correlation between the expression of these chemokines and NF-kappaB activation in the same cells, as observed in serial sections (r = 0.7; P = 0.01). In addition, the tubular expression of these chemokines was correlated mainly with the magnitude of the proteinuria (P = 0.002) and with interstitial cell infiltration (P<0.05)., Conclusions: The activation of NF-kappaB and the transcription of certain pro-inflammatory chemokines in tubular epithelial cells are markers of progressive DN. Proteinuria might be one of the main factors inducing the observed pro-inflammatory phenotype. more...
- Published
- 2004
- Full Text
- View/download PDF
16. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease.
- Author
-
Mezzano SA, Barría M, Droguett MA, Burgos ME, Ardiles LG, Flores C, and Egido J
- Subjects
- Adolescent, Adult, Chemokines metabolism, Child, Child, Preschool, Female, Glomerulonephritis, Membranous urine, Histocytochemistry, Humans, Immunohistochemistry, In Situ Hybridization, Inflammation Mediators metabolism, Male, Nephrosis, Lipoid urine, Proteinuria etiology, Reference Values, Glomerulonephritis, Membranous physiopathology, Kidney Tubules metabolism, NF-kappa B physiology, Nephrosis, Lipoid physiopathology, Transcription Factor AP-1 physiology
- Abstract
Background: Nuclear factor-kappaB (NF-kappaB) and activated protein-1 (AP-1) are transcription factors that regulate many genes involved in the progression of renal disease. Recent data have shown that NF-kappaB is activated in tubules and glomeruli in various experimental models of renal injury. In vitro studies also suggest that proteinuria could be an important NF-kappaB activator. We therefore approached the idea that NF-kappaB may be an indicator of renal damage progression., Methods: Paraffin-embedded renal biopsy specimens from 34 patients with intense proteinuria [14 with minimal change disease (MCD) and 20 with idiopathic membranous nephropathy (MN)] and from 7 patients with minimal or no proteinuria (IgA nephropathy) were studied by Southwestern histochemistry for the in situ detection of activated transcription factors NF-kappaB and AP-1. In addition, by immunohistochemistry, we performed staining for the NF-kappaB subunits (p50 and p65) and AP-1 subunits (c-fos, c-jun). By immunohistochemistry and/or in situ hybridization, the expression of some chemokines [monocyte chemoattractant protein-1 (MCP-1), RANTES, osteopontin (OPN)] and profibrogenic cytokines [transforming growth factor-beta (TGF-beta)], whose genes are regulated by NF-kappaB and/or AP-1, were studied further., Results: NF-kappaB was detected mainly in the tubules of proteinuric patients, but rarely in nonproteinuric IgA nephropathy (IgAN) patients. In addition, there was a significant relationship between the intensity of proteinuria and NF-kappaB activation in MCD (r = 0.64, P = 0.01) and MN patients (r = 0.64, P < 0.01). Unexpectedly, patients with MCD had a significantly higher NF-kappaB tubular activation than those with MN (P < 0.01). To assess whether there was a different composition of NF-kappaB protein components, immunostaining was performed for the NF-kappaB subunits p50 and p65. However, no differences were noted between MCD and MN patients. In those patients, there was a lower tubular activation of AP-1 compared with NF-kappaB. Moreover, a strong correlation in the expression of both transcription factors was observed only in MN (r = 0.7, P = 0.004). Patients with progressive MN had an overexpression of MCP-1, RANTES, OPN, and TGF-beta, mainly in the proximal tubules, while no significant expression was found in MCD patients., Conclusions: On the whole, our results show that a tubular overactivation of NF-kappaB and AP-1 and a simultaneous up-regulation of certain proinflammatory and profibrogenic genes are markers of progressive renal disease in humans. Increased activation of solely NF-kappaB and/or AP-1 may merely indicate the response of tubular renal cells to injury. more...
- Published
- 2001
- Full Text
- View/download PDF
17. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.
- Author
-
Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, and Egido J
- Subjects
- Adult, Aged, Female, Fibroblasts metabolism, Glomerulonephritis, Membranous pathology, Humans, Immunohistochemistry, In Situ Hybridization, Kidney metabolism, Macrophages pathology, Male, Middle Aged, Chemokines genetics, Cytokines genetics, Glomerulonephritis, Membranous metabolism
- Abstract
Unlabelled: Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy., Background: Proteinuria plays a central role in the progression of glomerular disease, and there is growing evidence suggesting that it may determine tubular cell activation with release of chemokines and fibrogenic factors, leading to interstitial inflammatory reaction. However, most studies on this subject have been performed in experimental models, and the experience in human kidney biopsies has been scarce. We analyzed the tissue sections of patients with idiopathic membranous nephropathy (IMN), a noninflammatory glomerular disease that may follow a progressive disease with heavy persistent proteinuria, interstitial cell infiltration, and decline of renal function., Methods: Paraffin-embedded biopsy specimens from 25 patients with IMN (13 progressive and 12 nonprogressive) were retrospectively studied by immunohistochemistry [monocyte chemoattractant protein-1 (MCP-1), regulated on activation normal T-cell expressed and secreted chemokine (RANTES), osteopontin (OPN), platelet-derived growth factor-BB (PD-GF-BB)] and in situ hybridization [MCP-1, RANTES, PDGF-BB, transforming growth factor-beta1 (TGF-beta1)]. Moreover, we studied the presence of myofibroblasts, which were identified by the expression of alpha-smooth muscle actin (alpha-SMA), the monocytes/macrophages (CD68-positive cells), and T-cell infiltration (CD4+ and CD8+ cells). All of the patients were nephrotic and without treatment at time of the biopsy., Results: A strong up-regulation of MCP-1, RANTES, and OPN expression was observed, mainly in tubular epithelial cells, with a significant major intensity in the progressive IMN patients. A strong correlation between the mRNA expression and the corresponding protein was noted. The presence of these chemokines and OPN was associated with interstitial cell infiltration. TGF-beta and PDGF were also up-regulated, mainly in tubular epithelial cells, with a stronger expression in the progressive IMN, and an association with the presence of myofibroblasts was found., Conclusions: Patients with severe proteinuria and progressive IMN have an overexpression in tubular epithelial cells of the chemokines MCP-1, RANTES, and OPN and the profibrogenic cytokines PDGF-BB and TGF-beta. Because this up-regulation was associated with an interstitial accumulation of mononuclear cells and an increase in myofibroblastic activity, it is suggested that those mediators are potential predictors of progression in IMN. Finally, based on experimental data and the findings of this article, we speculate that severe proteinuria is the main factor responsible for the up-regulation of these factors in tubular epithelial cells. more...
- Published
- 2000
- Full Text
- View/download PDF
18. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
- Author
-
Zhao MH, Jayne DR, Ardiles LG, Culley F, Hodson ME, and Lockwood CM
- Subjects
- Adolescent, Adult, Antibodies, Antineutrophil Cytoplasmic, Antimicrobial Cationic Peptides, Biomarkers blood, Blotting, Western, Cross-Sectional Studies, Cystic Fibrosis complications, Cystic Fibrosis physiopathology, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin A blood, Immunoglobulin G blood, Lung physiopathology, Male, Vasculitis complications, Vasculitis immunology, Autoantibodies blood, Blood Proteins immunology, Cystic Fibrosis immunology, Membrane Proteins
- Abstract
Cystic fibrosis (CF), a genetic disorder, is characterized by chronic pulmonary infection/inflammation which leads to respiratory failure. The presence of anti-neutrophil cytoplasmic autoantibodies (ANCA) has previously been observed in the sera of patients with CF. In view of the known relationship of ANCA with primary vasculitis and of their putative pathogenetic role in these disorders, we studied the presence, specificity and isotype of ANCA and their clinical associations in 66 adult CF patients. None of the 66 CF samples had autoantibodies to the major ANCA antigens, proteinase 3 or myeloperoxidase. However, 60/66 (91%) CF samples contained IgG, and 55/66 (83%) IgA, autoantibodies to bactericidal/permeability-increasing protein (BPI), a recently-characterized ANCA specificity. All the IgA anti-BPI-positive samples were also IgG anti-BPI-positive. The autoantibody specificity was confirmed by inhibition assay and immunoblotting of CF sera against a neutrophil granule preparation. Furthermore, in this cross-sectional study, anti-BPI levels were inversely correlated with the observed reductions in FEV1 and FVC (IgA anti-BPI & FEV1: r = -0.508, p < 0.0001), and both IgG and IgA anti-BPI levels were higher in CF patients with secondary vasculitis (n = 6) than in those without (p < 0.05). ANCA with specificity for BPI were present in the majority of CF sera in this study and autoimmune processes may be associated with the development of pulmonary injury in CF. more...
- Published
- 1996
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.